Alaunos Therapeutics Company

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.
Technology: Cell-based gene therapy
Industry: Public
Headquarters: New York, New York, United States
Founded Date: 2005-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 9
Total Funding: 293392527
Estimated Revenue: Less than $1M
Last Funding Date: 2022-11-29
Last Funding Type: Post-IPO Equity

Visit Website
info@ziopharm.com
http://twitter.com/ZIOPHARM
Register and Claim Ownership